P7C3-OMe is primarily researched for its neuroprotective properties, showing potential in mitigating neuronal cell death. It has been studied in preclinical models for its ability to enhance neurogenesis, making it a candidate for treating neurodegenerative diseases such as Alzheimer's and Parkinson's. Additionally, it has shown promise in reducing brain damage following traumatic brain injury and stroke. Its mechanism involves stabilizing mitochondrial function and promoting cell survival, which could also extend to applications in other conditions involving cellular degeneration or injury.